- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Is Trump Softening Stance on Controlling Drug Prices?
What we're reading, November 16, 2016: Donald Trump seems to be backing away from his hard stance on controlling drug prices; DC lawmakers pass assisted suicide law; and doctors often do not consider cost a top issue when deciding on treatments.
Completely repealing the Affordable Care Act is not the only campaign promise President-elect Donald Trump is already backpedaling on. According to the Los Angeles Times, Trump seems to be backing off his plans to control rising drug prices. The subject of pharmaceutical prices hasn’t been raised since the election, but it remains the top healthcare issue among Americans. The Trump agenda on healthcare has 6 healthcare priorities, but doesn’t mention drug prices.
In the District of Columbia, lawmakers passed an assisted suicide bill by a vote of 11-2. The bill needs the mayor’s signature, at which point it goes to Congress for review, reported The Washington Post. DC’s “Death with Dignity” bill allows terminally ill patients who have less than 6 months to live to request lethal medication from a doctor. Congress can undo any laws passed by the District of Columbia.
A survey of more than 800 doctors found that cost is not often an important consideration when deciding treatment. Among 6 types of doctors surveyed, only primary care physicians said cost was one of the most important factors, behind drug safety, efficacy, and if the drug is well tolerated, according to STAT. Among oncologists, cost was only the sixth most important issue, and pulmonologists ranked it last.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
